Our client was weighing a high-stakes acquisition but lacked the clarity needed to move forward with confidence. The product showed strong potential, but critical questions remained unanswered. How was the disease area evolving? What was the market landscape really like? What kind of internal investment would be required to succeed? We were brought in not just to provide information, but to solve the core problem: giving the client a fast, comprehensive, and actionable view of whether this was an opportunity worth pursuing.
We began by integrating multiple sources of evidence to evaluate the commercial landscape and highlight key drivers of success. This included structured literature reviews, social media listening, expert mapping, and competitor intelligence.
We analysed stakeholder engagement across channels, tracked the volume and tone of online discussion, and benchmarked the visibility and perceived value of competitor products. Our team also delivered a view of how the conversation was shifting over time, where gaps and unmet needs remained, and how future influencers might shape the market.
Alongside this, we evaluated the resource implications of acquiring and launching the asset—looking at expected demands across medical, commercial, and communications teams.
We delivered a tailored market access and business intelligence report, supported by a live intelligence board. This included:
The client left with a strong evidence base for their acquisition decision. They understood both the potential of the asset and what it would take to maximise its value within their portfolio. The analysis supported internal alignment across functions and gave the leadership team confidence to proceed with a clear commercial plan.
We continue to support the client with live monitoring and updates through the intelligence board, helping them navigate early-stage integration and lay the groundwork for launch activities.
